Veloxis Pharmaceuticals A/S 15.10.2012 09:44
---------------------------------------------------------------------------
Not for release, publication or distribution in the United States, Canada, Australia or Japan This prospectus does not constitute an offer to sell or the solicitation of an offer to buy the securities of Veloxis Pharmaceuticals A/S (the 'Securities') in the United States or in any other jurisdiction. The Securities may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended. The issuer of the Securities has not registered, and does not intend to register, any portion of the Offering in the United States or in any jurisdiction outside Denmark, and does not intend to conduct a public offering of the Securities in the United States or in any other jurisdiction outside Denmark. Copies of this prospectus are not being made and may not be distributed or sent into the United States, Canada, Australia or Japan or any other jurisdiction where such distribution is not permitted under the applicable laws of such jurisdiction. The prospectus is attached. Click on, or paste the following link into your web browser, to view the associated documents https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=406245 News Source: NASDAQ OMX 15.10.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English Company: Veloxis Pharmaceuticals A/S Dänemark Phone: Fax: E-mail: Internet: ISIN: DK0060048148 WKN: End of Announcement DGAP News-Service
---------------------------------------------------------------------------
---------------------------------------------------------------------------
Not for release, publication or distribution in the United States, Canada, Australia or Japan This prospectus does not constitute an offer to sell or the solicitation of an offer to buy the securities of Veloxis Pharmaceuticals A/S (the 'Securities') in the United States or in any other jurisdiction. The Securities may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended. The issuer of the Securities has not registered, and does not intend to register, any portion of the Offering in the United States or in any jurisdiction outside Denmark, and does not intend to conduct a public offering of the Securities in the United States or in any other jurisdiction outside Denmark. Copies of this prospectus are not being made and may not be distributed or sent into the United States, Canada, Australia or Japan or any other jurisdiction where such distribution is not permitted under the applicable laws of such jurisdiction. The prospectus is attached. Click on, or paste the following link into your web browser, to view the associated documents https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=406245 News Source: NASDAQ OMX 15.10.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English Company: Veloxis Pharmaceuticals A/S Dänemark Phone: Fax: E-mail: Internet: ISIN: DK0060048148 WKN: End of Announcement DGAP News-Service
---------------------------------------------------------------------------
